HER2estäjähoitoa
HER2estäjähoito, known in English as HER2-targeted therapy, is a type of cancer treatment that focuses on inhibiting the HER2 protein. This protein, also known as Human Epidermal growth factor Receptor 2, is a receptor tyrosine kinase that plays a role in cell growth and division. In certain types of cancer, such as some breast and stomach cancers, the HER2 gene is amplified, leading to an overexpression of the HER2 protein on the surface of cancer cells. This overexpression can drive the aggressive growth and proliferation of these cancer cells.
HER2estäjähoito works by targeting this specific protein. Medications used in this therapy are designed to bind